miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
Jieun LeeHee Eun KimYoung-Seok SongEun Yoon ChoAh Won LeePublished in: Breast cancer research and treatment (2019)
miR-106b-5p and miR-17-5p might have a role in breast cancer recurrence and progression by suppressing TGF-β activity, leading to early breast cancer carcinogenesis.